The child may experience withdrawal signs of neonatal abstinence syndrome. However, this is not a fatal condition but will result in prolonged hospitalization and significant illnesses. The child will demonstrate some signs like tremor and irritability, poor sleep, exaggerated Moro reflex, poorly coordinated feeding, failure to thrive and vomiting ("Opioid Use in Pregnancy Affects Offspring Across Childhood", 2019). The child will require an inpatient pharmacologicalintervention. Postnatal physical health risks and underdevelopment health outcomes will be experienced in the overall sample. the child will have a higher percentage of conducting
WOMEN HEALTH CARE3emotional disturbance disorders. The long-term consequences of the neonatal abstinence syndrome will be ADHD. Early intervention will help overcome the condition from future occurrence. For a successful supportive management of the infants and mothers that are exposed to opioids during pregnancy, the caregiver will consider a number of factors. One of the factors is ensuring to provide the mother and the child proper medication. Using of the accurate tools to evaluate the symptoms (Yeoh et al., 2019). The main treatment goal is to prevent the future occurrence of the complications that are associated with NAS to restore the normal newborn activities like sleep, weight gain, sufficient feeding and environmental adaptation.